Fbxo2通过调节YTHDF2无化和降解来抑制前列腺癌的进展
Xinyu Xu1,2, Guangcheng Dai1, Chun-Ling Liu3
1Department of Urology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Cell death & disease
|December 29, 2025
概括
在前列腺癌 (PCa) 中,F-box蛋白2 (Fbxo2) 通过向瘤蛋白YTHDF2进行降解,起到瘤抑制作用. 恢复Fbxo2水平可能为PCa患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- E3无素酶放松调控与前列腺癌 (PCa) 进展有关,但机制尚不清楚.
- F-box蛋白2 (Fbxo2),是SCF E3泛基因结合酶的组成部分,在PCa中起着未知的作用.
- YTHDF2是一种在PCa上调节的瘤蛋白,促进瘤进展.
研究的目的:
- 研究Fbxo2在前列腺癌进展中的作用.
- 确定Fbxo2的目标,并阐明其在PCa中的作用机制.
主要方法:
- 对Fbxo2表达的前列腺组织样本的分析.
- 在体外和体外功能测定以评估Fbxo2对PCa细胞的影响.
- 同免疫沉质谱 (co-IP-MS) 和西部抹杀用于识别Fbxo2目标.
- 乌比基因检测和位点定向突变发生,以确认YTHDF2的乌比基因化.
- 救援实验验证实Fbxo2和YTHDF2.2之间的功能相互作用.
主要成果:
- 在PCa中,Fbxo2的下调,其更高的表达与更好的预后相关.
- 过度表达Fbxo2可以抑制PCa细胞的增殖和转移.
- 鉴定出YTHDF2是Fbxo2介导的泛化和降解的基质.
- YTHDF2的lysine 286 (K286) 是关键的无处不在的部位.
- YTHDF2通过调节CDKN1CmRNA的m6A甲基化来促进PCa的进展.
结论:
- 在前列腺癌中,Fbxo2作为瘤抑制剂起作用.
- Fbxo2-YTHDF2轴调节PCa细胞的增殖和转移.
- Fbxo2可以作为PCa的预后生物标志物和治疗标.
相关概念视频
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Loss of Tumor Suppressor Gene Functions
5.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K


